Biophan to Be Issued Two New Patents

Biophan Technologies, a developer of next-generation biomedical technology, has announced that the U.S. Patent and Trademark Office will issue on April 5 two new patents involving proprietary developments that enable magnetic resonance imaging (MRI) of heart activity and advance the manufacture of nanoparticle coatings for medical devices.

One of the newly issued patents is part of a suite of Biophan patents that cover a wide array of technology solutions in MRI safety for implanted medical devices. This particular patent focuses on the method for use of a photonic, or fiber optic, lead that avoids MRI interference. It is intended for use in numerous biomedical diagnostic applications that require the sensing of electromagnetic fields at the body surface, and the transmission of information about those fields along the photonic lead.

The other newly issued patent describes specific details that relate to the creation of a layered electromagnetic shielding assembly from nanoparticulates consisting of relatively common materials such as aluminum, iron, nickel and cobalt. Various medical applications of this technology are under license to Biophan.